Their discovery of an antibody-based treatment, or 'anti-TNF' therapy, for the treatment of rheumatoid arthritis and other inflammatory diseases has transformed the lives of many patients.
Major prize for transforming rheumatoid arthritis treatment
- 26 March 2014
- Awards and Appointments
Sir Marc Feldmann and Sir Ravinder Maini of the Kennedy Institute of Rheumatology have been named 2014 Canada Gairdner Award winners, one of the world's most prestigious awards for medical research.